dexmethylphenidate hydrochloride has been researched along with Attention Deficit Disorder with Hyperactivity in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 26 (65.00) | 29.6817 |
| 2010's | 12 (30.00) | 24.3611 |
| 2020's | 2 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ehret, MJ; Pheils, J | 1 |
| Avillach, P; Feroe, AG; Greenspun, P; Gutiérrez-Sacristán, A; Kohane, IS; Mousavi, S; Surati, R; Uppal, N | 1 |
| Koller, L; Nguyen, LV; Patrick, KS; Radke, JL; Raymond, JR; Rodriguez, W; Straughn, AB | 1 |
| Francis, RN; Lambert, JM; Mastel, MA; O'Flaherty, CA; Picou, CG; Torelli, JN; Vandelaar, EM | 1 |
| Bishop, J; Cook, EH; Kittles, R; Newcorn, J; Stein, MA; Waldman, I | 1 |
| Bogner, R; Ehret, MJ; Sugrue, D | 1 |
| Bergmame, L; Gruber, R; Santisteban, JA; Stein, MA | 1 |
| Castelo, E; Cowen, J; Levitt, J; McCracken, JT; McGough, JJ; Sayer, GR; Sturm, A | 1 |
| Bussing, R; Kubilis, P; Liu, X; Winterstein, AG | 1 |
| Findling, RL | 1 |
| Brams, M; Mao, A; McCague, K; Muniz, R; Pestreich, L; Silva, R | 1 |
| Borrello, M; Brams, M; Childress, A; Giblin, J; Lopez, FA; Mao, A; McCague, K; Muniz, R; Silva, R; Turnbow, J | 1 |
| Adler, LA; Jiang, H; McGough, JJ; Muniz, R; Spencer, T | 1 |
| Angstadt, K; Bogart, GT; Chavez, B; Ehret, MJ; Goldberg, KR; Paulino, RE; Sopko, MA | 1 |
| Childress, AC; Gerstner, O; Lopez, F; Muniz, R; Post, A; Spencer, T; Thulasiraman, A | 1 |
| Coury, D | 1 |
| Keam, SJ; Moen, MD | 1 |
| Kratochvil, CJ; May, DE | 1 |
| Bauer, CC; Brandt, BC; Castellanos, FX; Coffey, BJ; Conelea, C; Howard, J; Kemp, JJ; Lawrence, ZE; Lipinski, CM; Lyon, GJ; Samar, SM; Trujillo, MR; Woods, D | 1 |
| Aryal, S; Charney, E; Gruber, R; Newcorn, JH; Sable, C; Stein, MA; Waldman, ID | 1 |
| Brams, M; Childress, A; Giblin, J; McCague, K; Muniz, R; Pestreich, L; Turnbow, J | 1 |
| Capellà, D; Castells, X; Cunill, R | 1 |
| Figgitt, DP; Keating, GM | 1 |
| Freid, J; Greenhill, L; Lerner, M; Posner, K; Steinhoff, K; Swanson, JM; Wigal, S; Wigal, T | 1 |
| Casat, CD; Conners, CK; Elia, J; Feifel, D; Sangal, RB; Swanson, JM; Wigal, S; Zeldis, JB | 1 |
| Patin, J; Wasdell, M; Weiss, M | 1 |
| Arnold, LE; Bohan, TP; Conners, CK; Johnson, DE; Levine, AJ; Lindsay, RL; Sangal, RB; West, SA; Wigal, SB; Zeldis, JB | 1 |
| Cecil, JT; Faleck, H; Khetani, V; Kowalik, S; Patin, J; Silva, R; Tilker, HA | 1 |
| McGough, JJ; Pataki, CS; Suddath, R | 1 |
| Keating, GM; Robinson, DM | 1 |
| Brams, M; Childress, A; Lopez, FA; Muniz, R; Pestreich, L; Silva, RR; Wang, J | 1 |
| Ball, RR; Greenhill, LL; Jiang, H; Levine, A; Muniz, R; Pestreich, L | 1 |
| Adler, LA; Jiang, H; McGough, JJ; Muniz, R; Pestreich, L; Spencer, TJ | 1 |
| Kowalik, S; Minami, H; Silva, R | 1 |
| Brams, M; Childress, A; Mao, AR; Muniz, R; Pestreich, L; Silva, RR; Wang, J | 1 |
| Brams, M; Childress, A; Mao, A; McCague, K; Muniz, R; Silva, R | 1 |
| Quinn, D | 1 |
11 review(s) available for dexmethylphenidate hydrochloride and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
Drug Regimen Individualization for Attention-Deficit/Hyperactivity Disorder: Guidance for Methylphenidate and Dexmethylphenidate Formulations.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Dosage Forms; Drug Administration Schedule; Humans; Methylphenidate; Precision Medicine | 2019 |
Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Capsules; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Humans; Methylphenidate; Tablets | 2014 |
Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Topics: Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dexmethylphenidate Hydrochloride; Humans; Methylphenidate; Norepinephrine Plasma Membrane Transport Proteins; Prodrugs; Propylamines | 2008 |
An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Amphetamines; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Controlled Clinical Trials as Topic; Dexmethylphenidate Hydrochloride; Dosage Forms; Humans; Methylphenidate; Practice Patterns, Physicians' | 2009 |
Dexmethylphenidate extended release: a review of its use in the treatment of attention-deficit hyperactivity disorder.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Dose-Response Relationship, Drug; Drug Interactions; Humans; Methylphenidate; Psychiatric Status Rating Scales; Severity of Illness Index | 2009 |
Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Chi-Square Distribution; Dexmethylphenidate Hydrochloride; Drug Administration Schedule; Endpoint Determination; Female; Humans; Male; Methylphenidate; Odds Ratio; Patient Dropouts; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome | 2013 |
Dexmethylphenidate.
Topics: Absorption; Attention Deficit Disorder with Hyperactivity; Child; Dexmethylphenidate Hydrochloride; Dopamine Uptake Inhibitors; Female; Humans; Male; Methylphenidate; Randomized Controlled Trials as Topic; Stereoisomerism; Treatment Outcome | 2002 |
Dexmethylphenidate--Novartis/Celgene. Focalin, D-MPH, D-methylphenidate hydrochloride, D-methylphenidate, dexmethylphenidate, dexmethylphenidate hydrochloride.
Topics: Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Dexmethylphenidate Hydrochloride; Dopamine Uptake Inhibitors; Humans; Methylphenidate; Norepinephrine | 2002 |
Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorder.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Capsules; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Humans; Methylphenidate | 2005 |
Dexmethylphenidate extended-release capsules for the treatment of attention deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Capsules; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Humans; Methylphenidate; Stereoisomerism | 2006 |
Does chirality matter? pharmacodynamics of enantiomers of methylphenidate in patients with attention-deficit/hyperactivity disorder.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Corpus Striatum; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Dopamine; Humans; Methylphenidate; Papio; Positron-Emission Tomography; Stereoisomerism; Structure-Activity Relationship | 2008 |
18 trial(s) available for dexmethylphenidate hydrochloride and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Amphetamines; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Dexmethylphenidate Hydrochloride; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Double-Blind Method; Female; Genotype; Humans; Male | 2014 |
Effect of extended-release dexmethylphenidate and mixed amphetamine salts on sleep: a double-blind, randomized, crossover study in youth with attention-deficit hyperactivity disorder.
Topics: Actigraphy; Adolescent; Amphetamines; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Salts; Sleep; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2014 |
Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Guanfacine; Heart Rate; Humans; Male; Time Factors | 2016 |
Efficacy and safety of extended-release dexmethylphenidate compared with d,l-methylphenidate and placebo in the treatment of children with attention-deficit/hyperactivity disorder: a 12-hour laboratory classroom study.
Topics: Attention Deficit Disorder with Hyperactivity; Chemistry, Pharmaceutical; Child; Cross-Over Studies; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Male; Methylphenidate; Placebos; Schools; Social Environment; Time Factors; Treatment Outcome | 2008 |
A randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder: rapid onset of effect.
Topics: Analysis of Variance; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Dexmethylphenidate Hydrochloride; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Drug Evaluation; Female; Humans; Male; Methylphenidate; Personality Assessment; Psychiatric Status Rating Scales; Retrospective Studies; Time Factors; Treatment Outcome | 2008 |
Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Attention Deficit Disorder with Hyperactivity; Capsules; Central Nervous System Stimulants; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Methylphenidate; Middle Aged; Personality Assessment; Treatment Outcome; Young Adult | 2009 |
Efficacy and safety of dexmethylphenidate extended-release capsules administered once daily to children with attention-deficit/hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Capsules; Child; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Methylphenidate; Nervous System Diseases; Skin Diseases | 2009 |
Testing tic suppression: comparing the effects of dexmethylphenidate to no medication in children and adolescents with attention-deficit/hyperactivity disorder and Tourette's disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Combined Modality Therapy; Cross-Over Studies; Dexmethylphenidate Hydrochloride; Female; Humans; Male; Methylphenidate; Pilot Projects; Reinforcement, Psychology; Tics; Tourette Syndrome | 2010 |
Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts.
Topics: Adolescent; Amphetamines; Appetite; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Methylphenidate; Psychiatric Status Rating Scales; Sleep Initiation and Maintenance Disorders | 2011 |
A randomized, double-blind study of 30 versus 20 mg dexmethylphenidate extended-release in children with attention-deficit/hyperactivity disorder: late-day symptom control.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Methylphenidate; Time Factors; Treatment Outcome | 2012 |
A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
Topics: Administration, Oral; Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dexmethylphenidate Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Methylphenidate; Placebos; Severity of Illness Index; Stereoisomerism; Treatment Outcome | 2004 |
A double-blind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dexmethylphenidate Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Methylphenidate; Psychiatric Status Rating Scales; Stereoisomerism; Treatment Outcome; Withholding Treatment | 2004 |
Open-label study of dexmethylphenidate hydrochloride in children and adolescents with attention deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dexmethylphenidate Hydrochloride; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Methylphenidate; Pilot Projects; Prospective Studies; Psychiatric Status Rating Scales; Stereoisomerism; Treatment Outcome | 2004 |
Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder.
Topics: Aptitude Tests; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Double-Blind Method; Female; Humans; Male; Mathematics; Methylphenidate; Psychiatric Status Rating Scales; Treatment Outcome | 2006 |
Efficacy and safety of dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Double-Blind Method; Female; Humans; Isomerism; Male; Methylphenidate; Treatment Outcome | 2006 |
Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Methylphenidate; Reproducibility of Results; Severity of Illness Index; Surveys and Questionnaires | 2007 |
Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Methylphenidate; Personality Assessment; Social Environment; Stereoisomerism; Treatment Outcome | 2008 |
Treatment of children with attention-deficit/hyperactivity disorder: results of a randomized, multicenter, double-blind, crossover study of extended-release dexmethylphenidate and D,L-methylphenidate and placebo in a laboratory classroom setting.
Topics: Area Under Curve; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over Studies; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Double-Blind Method; Female; Humans; Male; Methylphenidate; Placebos | 2008 |
11 other study(ies) available for dexmethylphenidate hydrochloride and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
Update on methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Half-Life; Humans; Methylphenidate | 2021 |
Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database.
Topics: Adolescent; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Bupropion; Child; Child, Preschool; Cohort Studies; Comorbidity; Data Mining; Depressive Disorder, Major; Dexmethylphenidate Hydrochloride; Dextroamphetamine; Female; Health Services Accessibility; Humans; Insurance; Lisdexamfetamine Dimesylate; Male; Managed Care Programs; Prevalence; Retrospective Studies | 2021 |
Effects of Dexmethylphenidate on Targeted and Non-Targeted Behaviours during Functional Analyses: A Brief Report.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dexmethylphenidate Hydrochloride; Humans; Male; Problem Behavior | 2019 |
Development of a refill pattern method to measure polypharmacy in administrative claims databases.
Topics: Adolescent; Algorithms; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Databases, Factual; Dexmethylphenidate Hydrochloride; Female; Humans; Male; Methylphenidate; Pharmacoepidemiology; Polypharmacy; Time Factors | 2016 |
Focalin XR for ADHD.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Humans; Methylphenidate; Treatment Outcome | 2009 |
Dexmethylphenidate for attention deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dexmethylphenidate Hydrochloride; Humans; Methylphenidate | 2009 |
Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy.
Topics: Administration, Oral; Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dexmethylphenidate Hydrochloride; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Drug Therapy, Combination; Half-Life; Health Care Costs; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Pediatrics; Prodrugs; Propylamines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
The use of a laboratory school protocol to evaluate concepts about efficacy and side effects of new formulations of stimulant medications.
Topics: Amphetamines; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Methylphenidate; Randomized Controlled Trials as Topic; Structure-Activity Relationship; Treatment Outcome | 2002 |
A post hoc analysis of d-threo-methylphenidate hydrochloride (focalin) versus d,l-threo-methylphenidate hydrochloride (ritalin).
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clinical Trials, Phase III as Topic; Dexmethylphenidate Hydrochloride; Humans; Methylphenidate; Retrospective Studies; Stereoisomerism; Treatment Outcome | 2004 |
Dexmethylphenidate extended release: in attention-deficit hyperactivity disorder.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dexmethylphenidate Hydrochloride; Dopamine Uptake Inhibitors; Humans; Methylphenidate; Middle Aged; Randomized Controlled Trials as Topic | 2006 |
Dexmethylphenidate (Focalin) for ADHD.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dexmethylphenidate Hydrochloride; Dosage Forms; Dose-Response Relationship, Drug; Humans; Methylphenidate; Randomized Controlled Trials as Topic; Stereoisomerism | 2002 |